Authors:
Francesca Battaglin, Joanne Xiu, Yasmine Baca, Jia Zeng, Anthony F. Shields, Richard M. Goldberg, Andreas Seeber, Diane Habib, Alberto Puccini, Ryuma Tokunaga, Hiroyuki Arai, Jingyuan Wang, Martin D. Berger, Igor Astaturov, A. Craig Lockhart, Wu Zhang, John L. Marshall, W. Michael Korn, Heinz-Josef Lenz, Anthony El-Khoueiry
Conclusions:
Our data show for the first time a distinct gene expression profile characterizing IDH mutant tumors which display significant downregulation of inflammatory response pathways and immune-related genes, coupled with significantly lower B cell infiltration and higher endothelial abundance. • These findings contribute to further the understanding of IDH mutant BC and may inform the future development of rational combination therapies.
Download PublicationCookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |